Phase 1b Study of an Anti-Siglec-8 Monoclonal Antibody, Antolimab (AK002), in Severe Allergic Conjunctivitis

antolimab (AK002) - Allakos

https://ascrs.confex.com/ascrs/20am/meetingapp.cgi/Paper/63730

Stephen D. Anesi, MD, FACS; Joseph Tauber, MD; Gregg J. Berdy, MD, FACS; Peter Y. Chang, MD; Henrik S. Rasmussen, MD, PhD; Charles S. Foster, MD, FACS

Mar 1, 2020